Bioasis Technologies Stock Net Asset
| BIOAF Stock | USD 0.0001 0.00 0.00% |
biOasis Technologies fundamentals help investors to digest information that contributes to BiOasis Technologies' financial success or failures. It also enables traders to predict the movement of BiOasis Pink Sheet. The fundamental analysis module provides a way to measure BiOasis Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiOasis Technologies pink sheet.
BiOasis |
biOasis Technologies Company Net Asset Analysis
BiOasis Technologies' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current BiOasis Technologies Net Asset | 2.27 M |
Most of BiOasis Technologies' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, biOasis Technologies has a Net Asset of 2.27 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
BiOasis Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BiOasis Technologies' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BiOasis Technologies could also be used in its relative valuation, which is a method of valuing BiOasis Technologies by comparing valuation metrics of similar companies.BiOasis Technologies is currently under evaluation in net asset category among its peers.
BiOasis Fundamentals
| Return On Asset | -0.81 | |||
| Operating Margin | (11.41) % | |||
| Current Valuation | 6 M | |||
| Shares Outstanding | 79.41 M | |||
| Shares Owned By Insiders | 2.05 % | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 53.47 X | |||
| Price To Sales | 26.52 X | |||
| Revenue | 37.73 K | |||
| Gross Profit | (1.15 M) | |||
| EBITDA | (3.54 M) | |||
| Net Income | (2.96 M) | |||
| Cash And Equivalents | 764.97 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 401.76 K | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 0.38 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.64 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 0.58 | |||
| Number Of Employees | 23 | |||
| Beta | 0.39 | |||
| Market Capitalization | 2.13 M | |||
| Total Asset | 2.27 M | |||
| Retained Earnings | (18.69 M) | |||
| Working Capital | 437 K | |||
| Current Asset | 874 K | |||
| Current Liabilities | 437 K | |||
| Z Score | -11.5 | |||
| Net Asset | 2.27 M |
About BiOasis Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiOasis Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BiOasis Pink Sheet
BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.